// App-Quantinova.ai

2714 : A Low Dose Heparinized Saline Protocol Is Associated with Improved Duration of Arterial Line Patency in Critically Ill COVID-19 Patients

Researchers

Presenter

  • Lydia R. Maurer

Principal Investigators

  • Casey M. Luckhurst

  • Arzo Hamidi

  • Kelly A. Newman

  • Megan E. Barra

  • Majed El Hechi

  • Ava Mokhtari

  • Kerry Breen

  • Laura Lux

  • Laura Prout

  • Jarone Lee

  • Edward A. Bittner

  • David Chang

  • Haytham M.A. Kaafarani

  • Russel J. Roberts

  • Rachel P. Rosovsky

Medical Centers

  • Department of Pathology, Massachusetts General Hospital, Boston, MA

  • Department of Pathology, Massachusetts General Hospital, Boston, MA

  • Division of Trauma, Emergency Surgery, and Surgical Critical Care, Massachusetts General Hospital, Boston, MA

  • Department of Pathology, Massachusetts General Hospital, Boston, MA

  • Dept of Medicine, Massachusetts General Hospital, Boston, MA

  • Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hosp, Boston, MA

  • Codman Center for Clinical Effectiveness in Surgery, Massachusetts General Hospital, Boston, MA

  • Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Venous thrombosis

  • Coronavirus disease

  • Obesity

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved